Pedro Renato de Paula Brandao

Scopus Publications

Clinical characteristics of the Ala21Val variant in the myelin proteolipid protein 1 (PLP1) gene associated with Pelizaeus-Merzbacher disease in a Brazilian male patient
Pedro Manzke, Pedro Renato P. Brandão, Talita Balieiro, Diógenes Diego de Carvalho Bispo, Maria Joana Osório, Gustavo Barcelos Barra
Human Genome Variation, 2025
Here, we report the case of a 29-year-old male with classic Pelizaeus-Merzbacher disease (PMD) harboring the PLP1 variant NM_000533.5:c.62 C > T, leading to an NP_000524.3:p.(Ala21Val) alteration in the first transmembrane domain of the protein. He presented with developmental delays, nystagmus, spastic paraparesis, optic atrophy, dysphagia, appendicular ataxia, and progressive head tremor. Brain MRI revealed hypomyelination, diffuse white matter hyperintensity, and atrophy of the corpus callosum and cerebellum, expanding the known clinical spectrum of PMD.
Sniffin’ sticks smell identification test: exploring measurement properties in an adult Brazilian healthcare professionals sample
Pedro Renato de Paula Brandão, Danilo Assis Pereira, Diógenes Diego de Carvalho Bispo, Felipe von Glehn, Laura Silveira-Moriyama, Simoneide Souza Titze-de-Almeida, Marcio Nakanishi, Felipe Saldanha-Araujo, Enrique Roberto Arganaraz, Adriana Pinheiro Ribeiro, Agda Lima dos Santos, Ricardo Titze-de-Almeida
Peerj, 2025
Introduction Olfactory evaluation has gained significant attention in both neurological and otorhinolaryngological assessments, particularly following the COVID-19 pandemic where SARS-CoV-2 infection emerged as a frequent cause of chemosensory dysfunction. The Sniffin’ Sticks identification test is a widely used screening tool for olfactory function. This study aimed to investigate the psychometric properties, specifically validity evidence based on internal structure (unidimensionality) and relations to other variables (demographic effects), of the 16-item Sniffin’ Sticks odor identification test (SS-16) in a homogeneous sample of highly educated young and middle-aged Brazilian adults, while exploring item-specific demographic effects. Methods A prospective observational cross-sectional study was conducted on 144 highly educated adults. The SS-16 was administered using the ‘Odor-on-lines’ paradigm. Rasch analysis assessed person-item mapping and fit statistics, while multiple regression analyses determined the effects of age, sex, and education on both overall and item-specific performance. Results Rasch analysis supported the unidimensionality of the SS-16. Item difficulty varied, with peppermint, cinnamon, and fish being easiest to identify, while apple, turpentine, and liquorice were the most challenging. Item-level analyses revealed specific demographic influences: older age was associated with poorer identification of coffee (β = −0.05, p = 0.021) and cloves (β = −0.123, p = 0.001); female sex was associated with significantly better identification of rose (β = 1.15, p = 0.026); and higher education level positively impacted identification of cloves and anise (β = 0.122, p = 0.011). These item-specific effects suggest potential differential age-related vulnerability for certain odorants, possible hormonal influences on floral odor detection, and educational effects potentially linked to semantic processing of complex aromas. Smell identification capacity was classified as “very low” (<P3, SS-16 score ≤10), “low” (≤P9, 11 points), “average” (P9.1–P84, 12–15 points), and “high” (>P84, 16 points). Conclusion This study provides insights into the psychometric properties of the SS-16 in a specific sample of Brazilian adults, demonstrating both general and item-specific demographic effects on olfactory performance. The identification of item-specific influences enhances understanding of the complex interplay between biological and sociocultural factors in olfaction. While the predominance of female participants and the homogeneous high educational profile limit broader generalizability, this analysis contributes preliminary reference data for this demographic and supports the potential utility of this culturally adapted SS-16 version for clinical screening in similar Brazilian settings. Future research requires more diverse samples to establish representative Brazilian norms.
Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer’s Disease: Advances and Perspectives in Translational Research
Simoneide Souza Titze-de-Almeida, Clara Luna Marina, Milena Vieira Ramos, Letícia Dias dos Santos Silva, Pedro Renato de Paula Brandão, Diógenes Diego de Carvalho Bispo, Felipe Von Glehn, Ricardo Titze-de-Almeida
International Journal of Molecular Sciences, 2025
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder primarily characterized by memory loss and cognitive decline, which significantly impacts patients’ quality of life and imposes substantial emotional, practical, and economic burdens on their families. As the most common cause of senile dementia, AD currently affects approximately 50 million people worldwide, with projections indicating a threefold increase by 2050 due to rising life expectancy and an aging global population. Diagnosis of AD remains challenging. Neuroimaging techniques reveal atrophy in critical brain regions, particularly in the cortex, hippocampus, and limbic system, which are essential substrates for memory, personality changes, and other cognitive functions. The hallmark molecular changes associated with AD include the accumulation of β-amyloid plaques and the formation of tau protein tangles. Several underlying mechanisms contribute to neuron loss, such as oxidative stress, neuroinflammation, microbial dysbiosis, and insulin resistance. In this context, exosomes—small extracellular vesicles that facilitate cell communication—transport proteins, DNA, mRNA, and non-coding RNA (ncRNA), all of which play a significant role in the neurobiology of AD. Furthermore, emerging research indicates that exosomal ncRNAs may serve as promising biomarkers for AD, offering the possibility of improved diagnostic precision. This review explores the potential of exosomal ncRNAs—specifically circular RNAs and microRNAS—as non-invasive biomarkers for AD, highlighting recent advances and future directions in translational studies.
Guidelines for Parkinson's disease management part II: consensus from the movement disorders scientific department of the Brazilian Academy of Neurology - non-motor symptoms
Débora Palma Maia, Rubens Gisbert Cury, Pedro Renato P. Brandão, Francisco E. C. Cardoso, Ana Paula Bertholo, André Carvalho Felicio, Arlete Hilbig, Bruno Lopes Santos Lobato, Eline Rozária F. Barbosa, Elizabeth Maria A. B. Quagliato, Gustavo H. C. Sousa, Jacy Bezerra Parmera, Márcia Rúbia, Marcus Vinícius Della Coletta, Maria Sheila Guimarães Rocha, Mariana Spitz, Mônica Haddad, Nina Rosa A. F. Murta, Paulo Caramelli, Raimundo N. D. Rodrigues, Ricardo Nitrini, Roberto Prado, Vitor Tumas, Ylmar Corrêa Neto, Roberta Arb Saba
Arquivos De Neuro Psiquiatria, 2025
The treatment of Parkinson's disease (PD) is a challenge, especially because it is considered highly individualized. The Brazilian Academy of Neurology (ABN) has identified the need to disseminate knowledge about its management, adapting the best evidence to the Brazilian population. The present article aims to report the recommendations for the treatment of non-motor symptoms of PD, developed by a group of specialists in movement disorders from the ABN's scientific department. In 2021, the first part, referring to the motor symptoms of PD, was published. The main non-motor symptoms were addressed—among them neuropsychiatric symptoms, such as depression, anxiety, cognitive alteration, and psychosis—as well as the possible recommended therapies and medications used to control pain, sleep disorders, and dysautonomia.
Development and validation of the MultiScent-20 digital odour identification test using item response theory
Marcio Nakanishi, Pedro Renato de Paula Brandão, Gustavo Subtil Magalhães Freire, Luis Gustavo do Amaral Vinha, Marco Aurélio Fornazieri, Wilma Terezinha Anselmo-Lima, Danilo Assis Pereira, Gustavo Henrique Campos de Sousa, Claudia Galvão, Thomas Hummel
Scientific Reports, 2024
Although validated and reliable psychophysical tests of olfactory function are available, an easy-to-use and feasible test has yet to be developed. This study aimed to design a digital odour identification test, evaluate its validity, assess its reliability, establish a normative curve, and explore the impact of demographic factors. The odour identification test was presented with the Multiscent-20, a hand-held, tablet-like digital scent device that features an integrated odour digital delivery system. The identification performance on the 20 odours was assessed using item response theory (IRT). The normative curve was established by administering the test to a large sample of participants (n = 1299). The mean identification score was 17.5 (SD = 2.1). The two-parameter logistic IRT model provided the best fit, revealing variation in item discrimination and difficulty parameters. Educational attainment influenced performance, with primary education associated with lower scores. Additionally, sex was not found to be associated with performance. This study provides initial evidence supporting the validity and reliability of use of the Multiscent-20 as a digital odour identification test. The test’s automation and portability enable the standardized delivery of olfactory stimuli and efficient automatic recording and scoring of responses.
A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries
Gabriela Magalhães Pereira, Daniel Teixeira-dos-Santos, Nayron Medeiros Soares, Gabriel Alves Marconi, Deise Cristine Friedrich, Paula Saffie Awad, Bruno Lopes Santos-Lobato, Pedro Renato P. Brandão, Alastair J. Noyce, Connie Marras, Ignacio F. Mata, Carlos Roberto de Mello Rieder, Artur Francisco Schumacher Schuh
Npj Parkinson S Disease, 2024
Parkinson's disease (PD) is a common neurodegenerative disease that is a growing public health challenge. Estimates of the burden of PD have focused on data from high-income countries, with lower-income countries poorly described. We reviewed and examined the prevalence of PD reported by studies in low- to upper-middle-income countries. A systematic literature search was performed in the Medline/PubMed, Embase, LILACS, and Web of Science databases. Age group, sex, and geographic region were considered when analyzing the data. Of the 4327 assessed articles, 57 met the inclusion criteria for qualitative review, and 36 were included in the meta-analysis. Heterogeneity measures were high both as a whole and in each geographic region. Data analysis by geographic region showed that reported prevalence differed across regions, ranging from 49 per 100,000 (Sub-Saharan Africa) to 1081 per 100,000 (Latin America and the Caribbean). There was an increasing prevalence of PD with advancing age (per 100,000): 7 in 40-49 years, 158 in 50-59 years, 603 in 60-69 years, 1251 in 70-79 years, and 2181 in over the age of 80. The prevalence of PD in men and women was similar. There was a greater PD prevalence in populations with a higher 5-year GDP per capita and a higher life expectancy. Our findings suggest a higher prevalence of PD in lower and upper-middle-income countries than previously reported. Comparisons between regions are difficult, as the sociocultural differences and lack of methodological standardization hinder understanding key epidemiological data in varied populations.
Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson’s disease with mild cognitive impairment
Pedro Renato Brandão, Danilo Assis Pereira, Talyta Cortez Grippe, Diógenes Diego de Carvalho Bispo, Fernando Bisinoto Maluf, Ricardo Titze-de-Almeida, Brenda Macedo de Almeida e Castro, Renato Puppi Munhoz, Maria Clotilde Henriques Tavares, Francisco Cardoso
Frontiers in Neuroanatomy, 2024
BackgroundThe Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) is a widely used tool for detecting mild cognitive impairment (MCI) in Parkinson’s Disease (PD) patients, however, the neuroanatomical underpinnings of this test’s outcomes require clarification. This study aims to: (a) investigate cortical volume (CVol) and cortical thickness (CTh) disparities between PD patients exhibiting mild cognitive impairment (PD-MCI) and those with preserved cognitive abilities (PD-IC); and (b) identify the structural correlates in magnetic resonance imaging (MRI) of overall PD-CRS performance, including its subtest scores, within a non-demented PD cohort.Materials and methodsThis study involved 51 PD patients with Hoehn &amp; Yahr stages I–II, categorized into two groups: PD-IC (n = 36) and PD-MCI (n = 15). Cognitive screening evaluations utilized the PD-CRS and the Montreal Cognitive Assessment (MoCA). PD-MCI classification adhered to the Movement Disorder Society Task Force criteria, incorporating extensive neuropsychological assessments. The interrelation between brain morphology and cognitive performance was determined using FreeSurfer.ResultsVertex-wise analysis of the entire brain demonstrated a notable reduction in CVol within a 2,934 mm2 cluster, encompassing parietal and temporal regions, in the PD-MCI group relative to the PD-IC group. Lower PD-CRS total scores correlated with decreased CVol in the middle frontal, superior temporal, inferior parietal, and cingulate cortices. The PD-CRS subtests for Sustained Attention and Clock Drawing were associated with cortical thinning in distinct regions: the Clock Drawing subtest correlated with changes in the parietal lobe, insula, and superior temporal cortex morphology; while the PD-CRS frontal-subcortical scores presented positive correlations with CTh in the transverse temporal, medial orbitofrontal, superior temporal, precuneus, fusiform, and supramarginal regions. Additionally, PD-CRS subtests for Semantic and Alternating verbal fluency were linked to CTh changes in orbitofrontal, temporal, fusiform, insula, and precentral regions.ConclusionPD-CRS performance mirrors neuroanatomical changes across extensive fronto-temporo-parietal areas, covering both lateral and medial cortical surfaces, in PD patients without dementia. The observed changes in CVol and CTh associated with this cognitive screening tool suggest their potential as surrogate markers for cognitive decline in PD. These findings warrant further exploration and validation in multicenter studies involving independent patient cohorts.
Sleep and memory complaints in long COVID: an insight into clustered psychological phenotypes
Ricardo Titze-de-Almeida, Pedro Henrique Araújo Lacerda, Edson Pereira de Oliveira, Mariah Eduarda Ferreira de Oliveira, Yngrid Sallaberry Silva Vianna, Amanda Machado Costa, Eloísa Pereira dos Santos, Louise Marie Coelho Guérard, Matheus Augusto de Miranda Ferreira, Isabel Cristina Rodrigues dos Santos, Jéssica Daniele da Silva Gonçalves, Gabriel Ginani Ferreira, Simoneide Souza Titze-de-Almeida, Pedro Renato de Paula Brandão, Helena Eri Shimizu, Andrezza Paula Brito Silva, Raimundo Nonato Delgado-Rodrigues, and
Peerj, 2024
This study evaluated clinical features of individuals with long COVID (5–8 months after diagnosis) who reported sleep and memory problems (62 cases) compared to those without (52 controls). Both groups had a similar mean age (41 vs. 39 years). Around 86% of the participants were non-hospitalized at the time of infection, and none of them were vaccinated at that point. Subsequently, both cases and controls received the vaccine; however, the vaccination rates differed significantly between the groups (30.7% vs. 51.0%). Cases and controls had similar rates of symptoms at acute COVID phase. However, cases were more likely to experience coryza, dyspnea, headache, and nausea/vomiting during long COVID. Regarding new-onset symptoms in long COVID, 12.9% of cases had dyspnea, and 14.5% experienced nausea/vomiting, whereas in the control group there were only 1.9% and 0.0%, respectively. Cases also had a significantly higher prevalence of persistent headache (22.6% vs. 7.7%), and dyspnea (12.9% vs. 0.0). In addition, cases also showed an increased rate of mental health complaints: disability in daily activities (45.2% vs. 9.6%; P < 0.001); concentration/sustained attention difficulties (74.2% vs. 9.6%; P < 0.001); anxiety–Generalized Anxiety Disorder 2-item scale (GAD-2) ≥ 3 (66.1% vs. 34.6%; P = 0.0013); and “post-COVID sadness” (82.3% vs. 40.4%; P < 0.001). We observed a significant correlation between sadness and anxiety in cases, which was not observed in controls (P=0.0212; Spearman correlation test). Furthermore, the frequency of concomitant sadness and anxiety was markedly higher in cases compared to controls (59.7% vs. 19.2%) (P < 0.0001; Mann-Whitney test). These findings highlight a noteworthy association between sadness and anxiety specifically in cases. In conclusion, our data identified concurrent psychological phenotypes in individuals experiencing sleep and memory disturbances during long COVID. This strengthens the existing evidence that SARS-CoV-2 causes widespread brain pathology with interconnected phenotypic clusters. This finding highlights the need for comprehensive medical attention to address these complex issues, as well as major investments in testing strategies capable of preventing the development of long COVID sequelae, such as vaccination.
Altered structural connectivity in olfactory disfunction after mild COVID-19 using probabilistic tractography
Diógenes Diego de Carvalho Bispo, Pedro Renato de Paula Brandão, Danilo Assis Pereira, Fernando Bisinoto Maluf, Bruna Arrais Dias, Hugo Rafael Paranhos, Felipe von Glehn, Augusto César Penalva de Oliveira, Alexandre Anderson de Sousa Munhoz Soares, Maxime Descoteaux, Neysa Aparecida Tinoco Regattieri
Scientific Reports, 2023
We aimed to investigate changes in olfactory bulb volume and brain network in the white matter (WM) in patients with persistent olfactory disfunction (OD) following COVID-19. A cross-sectional study evaluated 38 participants with OD after mild COVID-19 and 24 controls, including Sniffin' Sticks identification test (SS-16), MoCA, and brain magnetic resonance imaging. Network-Based Statistics (NBS) and graph theoretical analysis were used to explore the WM. The COVID-19 group had reduced olfactory bulb volume compared to controls. In NBS, COVID-19 patients showed increased structural connectivity in a subnetwork comprising parietal brain regions. Regarding global network topological properties, patients exhibited lower global and local efficiency and higher assortativity than controls. Concerning local network topological properties, patients had reduced local efficiency (left lateral orbital gyrus and pallidum), increased clustering (left lateral orbital gyrus), increased nodal strength (right anterior orbital gyrus), and reduced nodal strength (left amygdala). SS-16 test score was negatively correlated with clustering of whole-brain WM in the COVID-19 group. Thus, patients with OD after COVID-19 had relevant WM network dysfunction with increased connectivity in the parietal sensory cortex. Reduced integration and increased segregation are observed within olfactory-related brain areas might be due to compensatory plasticity mechanisms devoted to recovering olfactory function.
Evaluation of the Cutaneous Silent Period in a Healthy Brazilian Population
Natalia S. C. Cunha, Talyta Grippe, Raphael Boechat-Barros, Rubens N.M. Fernandez, Pedro Renato P. Brandão, Robert Chen, Francisco Cardoso
Journal of Clinical Neurophysiology, 2023
Purpose: To establish cutaneous silent period (CSP) normative values and investigate the variables that may influence them. Methods: We tested 41 healthy subjects. All subjects underwent nerve conduction studies, and we evaluated the CSP in both arms. Results: Four subjects did not have CSP and were excluded. The analyses were performed in the healthy group composed of 23 women and 14 men, with a mean age of 35 (range, 19–64) years. The CSP median duration was 23.2 milliseconds (ms), with 2 to 98th percentile at 11.3 and 48.7 ms. The median onset latency was 87.9 (range, 72.9–109) ms, and the median end latency was 112 (range, 93.8–138) ms. The CSP onset latency positively correlated with height, whereas CSP end latency and duration were weakly but significantly associated with age. Some measurements of ulnar nerve conduction study also correlated with CSP measures. The interrater coefficients for the primary measures of onset and end latency demonstrates the reproducibility of the method. Conclusions: The CSP with the fifth digit stimulation and recording from the abductor digiti minimi muscle is a valid diagnostic tool that can be used in clinical practice.
Use of non-invasive stimulation in movement disorders: A critical review
Clecio Godeiro, Carina França, Rafael Bernhart Carra, Felipe Saba, Roberta Saba, Débora Maia, Pedro Brandão, Nasser Allam, Carlos R. M. Rieder, Fernando Cini Freitas, Tamine Capato, Mariana Spitz, Danilo Donizete de Faria, Marcela Cordellini, Beatriz A. A. G. Veiga, Maria Sheila G. Rocha, Ricardo Maciel, Lucio B. De Melo, Patricia D. S. Möller, Magno R. R. Júnior, Luís H. T. Fornari, Carlos E. Mantese, Egberto Reis Barbosa, Renato P. Munhoz, Marcus Vinicius Della Coletta, Rubens Gisbert Cury
Arquivos De Neuro Psiquiatria, 2023
Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil
Pedro Renato de Paula Brandão, Danilo Assis Pereira, Talyta Cortez Grippe, Diógenes Diego de Carvalho Bispo, Fernando Bisinoto Maluf, Márcia Pereira Yunes, Gilberto Nunes Filho, Cândida Helena Lopes Alves, Javier Pagonabarraga, Jaime Kulisevsky, Andressa Mátos Luiz da Costa, Cristiano Franco do Val Serafim, Ana Carolina da Bouza Ferreira, Arthur de Melo Monteiro Bastos, Ana Clara Fernandes Belchior, Beatriz Luna Coutinho de Almeida, Brenda Macedo de Almeida e Castro, Matheus Sampaio Matos, Rodrigo Cardoso de Matos, Gabriel de Almeida Rios, Lorena Oliveira Carneiro, Bianca Christie Costa da Mota, Lucas Ernesto do Rêgo Castro, Vitória Luísa Silveira Rocha, Maria Clotilde Henriques Tavares, Francisco Cardoso
Movement Disorders Clinical Practice, 2023
Floor and ceiling effects on the Montreal Cognitive Assessment in patients with Parkinson’s disease in Brazil
Brenda Hanae Bentes Koshimoto, Pedro Renato de Paula Brandão, Vanderci Borges, Henrique Ballalai Ferraz, Artur Francisco Schumacher-Schuh, Carlos Roberto de Mello Rieder, Maira Rozenfeld Olchik, Ignacio Fernandez Mata, Vitor Tumas, Bruno Lopes Santos-Lobato
Dementia E Neuropsychologia, 2023
Brain microstructural changes and fatigue after COVID-19
Diógenes Diego de Carvalho Bispo, Pedro Renato de Paula Brandão, Danilo Assis Pereira, Fernando Bisinoto Maluf, Bruna Arrais Dias, Hugo Rafael Paranhos, Felipe von Glehn, Augusto César Penalva de Oliveira, Neysa Aparecida Tinoco Regattieri, Lucas Scardua Silva, Clarissa Lin Yasuda, Alexandre Anderson de Sousa Munhoz Soares, Maxime Descoteaux
Frontiers in Neurology, 2022
New-onset movement disorders associated with covid-19
Pedro Renato P. Brandão, Talyta C. Grippe, Danilo A. Pereira, Renato P. Munhoz, Francisco Cardoso
Tremor and Other Hyperkinetic Movements, 2021
Genetics of Parkinson's disease in Brazil: A systematic review of monogenic forms
Bruno L. Santos-Lobato, Artur Schumacher-Schuh, Ignacio F. Mata, Grace H. Letro, Pedro Braga-Neto, Pedro R. P. Brandão, Clécio O. Godeiro-Junior, Marcus V. Della Coletta, Sarah T. Camargos, Vanderci Borges, Carlos R. M. Rieder, Vitor Tumas
Arquivos De Neuro Psiquiatria, 2021
Cognitive impairment in Parkinson's disease: A clinical and pathophysiological overview
Pedro Renato P. Brandão, Renato Puppi Munhoz, Talyta Cortez Grippe, Francisco Eduardo Costa Cardoso, Brenda Macedo de Almeida e Castro, Ricardo Titze-de-Almeida, Carlos Tomaz, Maria Clotilde Henriques Tavares
Journal of the Neurological Sciences, 2020
Baroreflex function in Parkinson's disease: Insights from the modified-Oxford technique
Jeann L. Sabino-Carvalho, Roberta A. Cartafina, Gabriel M. Guimarães, Pedro R. P. Brandão, James A. Lang, Lauro C. Vianna
Journal of Neurophysiology, 2020
Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case
Ingrid Faber, Pedro R.P. Brandão, Fiorella Menegatti, Diógenes D. de Carvalho Bispo, Fernando B. Maluf, Francisco Cardoso
Movement Disorders, 2020
How can neurophysiological studies help with movement disorders characterization in clinical practice? A review
Talyta GRIPPE, Natalia Spinola Costa da CUNHA, Pedro Renato de Paula BRANDÃO, Rubens Nelson Morato FERNANDEZ, Francisco Eduardo Costa CARDOSO
Arquivos De Neuro Psiquiatria, 2020
Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran
Simoneide S. Titze-de-Almeida, Pedro Renato de Paula Brandão, Ingrid Faber, Ricardo Titze-de-Almeida
Molecular Diagnosis and Therapy, 2020
Amilton Barreira: a mentor who left imprints on future neurologists
Pedro Renato P. Brandão, Luis Augusto Avansini Carnelos, Denise Melo
Arquivos De Neuro Psiquiatria, 2019
Is transcranial sonography useful for diagnosing parkinson’s disease in clinical practice?
Talyta Cortez Grippe, Nasser Allam, Pedro Renato de Paula Brandão, Danilo Assis Pereira, Francisco Eduardo Costa Cardoso, Ana Carolina Rodrigues Aguilar, Iruena Moraes Kessler
Arquivos De Neuro Psiquiatria, 2018
Decisions about deep brain stimulation therapy in Parkinson’s disease
Pedro Brandão, Talyta Cortez Grippe, Luiz Cláudio Modesto, André Gustavo Fonseca Ferreira, Flávia Martins da Silva, Flávio Faria Pereira, Marcelo Evangelista Lobo, Nasser Allam, Tiago da Silva Freitas, Renato P. Munhoz
Arquivos De Neuro Psiquiatria, 2018
Delayed hemiparkinsonism after closed head injury
Monalisa da Silveira Dias, Pedro Renato Brandão, Talyta Grippe, Cassio Jovem, Marcelo Gomes, Flávio Faria Pereira
Arquivos De Neuro Psiquiatria, 2018
A case of coenesthetic hallucinations treated with low-frequency repetitive transcranial magnetic stimulation
Allam Nasser, Juliana Sousa Batista, Pedro Brandão, Talyta Grippe
Brain Stimulation, 2017
Congenital mirror movements: Lack of decussation of pyramids
Pedro Brandão, Cassio Jovem, Joaquim Pereira Brasil-Neto, Carlos Tomaz, Maxime Descoteaux, Nasser Allam
Brain, 2014
Preparatory courses for medical residency: Students point of view
Silvana Marques e Silva, Viviane Fernandes Rosa, Pedro Renato de Paula Brandão, Ana Carolina de Oliveira, Paulo Gonçalves de Oliveira, João Batista de Sousa
Revista do Colegio Brasileiro De Cirurgioes, 2011
Low frequency (0.5Hz) rTMS over the right (non-dominant) motor cortex does not affect ipsilateral hand performance in healthy humans
Fernanda Weiler, Pedro Brandão, Jairo de Barros-Filho, Carlos Enrique Uribe, Valdir Filgueiras Pessoa, Joaquim Pereira Brasil-Neto
Arquivos De Neuro Psiquiatria, 2008
Relief of primary cervical dystonia symptoms by low frequency transcranial magnetic stimulation of the premotor cortex: Case report
Nasser Allam, Joaquim Pereira Brasil-Neto, Pedro Brandão, Fernanda Weiler, Jairo de Barros Filho, Carlos Tomaz
Arquivos De Neuro Psiquiatria, 2007

Pedro Renato de Paula Brandao

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS